Nearly 40% of people in the semaglutide group reported no heavy drinking days in the last month of treatment, compared with 20% in the placebo group
From the start, everything was clear and transparent, and I didnt feel pressured to commit
patches sold online for weight loss or blood sugar control do not have FDA approval, have not been tested in humans, and currently have no proven clinical benefit compared with standard GLP1 injections or pills
As supply stabilizes, the FDA is tightening rules
In simple terms, the Ozempic lawsuit alleges that Novo Nordisk prioritized market expansion over patient safety by failing to update its warning label with information about serious gastrointestinal risks as evidence accumulated over the years
prepping, perfecting his craft and tailoring the menu